Yasunori Iwata

Kanazawa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 136 publications

Interstitial palladin is associated with tubulointerstitial chronicity and adverse outcomes in patients with lupus nephritis.

Interstitial palladin is associated with tubulointerstitial chronicity and adverse outcomes in patients with lupus nephritis.

Journal: Lupus

Published: August 20, 2026

Anti-Glomerular Basement Membrane Antibody Disease Complicated by Complement-Mediated Thrombotic Microangiopathy: A Case Report.

Anti-Glomerular Basement Membrane Antibody Disease Complicated by Complement-Mediated Thrombotic Microangiopathy: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: August 19, 2026

Validation of the 2019 ACR/EULAR criteria for IgG4-related disease in a Japanese cardiovascular/retroperitoneal disease cohort: a multicentre retrospective study by the joint working group of the Japanese Circulation Society and the Ministry of Health, Labour and Welfare study group.

Validation of the 2019 ACR/EULAR criteria for IgG4-related disease in a Japanese cardiovascular/retroperitoneal disease cohort: a multicentre retrospective study by the joint working group of the Japanese Circulation Society and the Ministry of Health, Labour and Welfare study group.

Journal: EULAR rheumatology open

Published: June 29, 2026

Lower-dose glucocorticoid therapy achieves comparable outcomes in Japanese patients with lupus nephritis.

Lower-dose glucocorticoid therapy achieves comparable outcomes in Japanese patients with lupus nephritis.

Journal: Lupus

Published: May 06, 2026

Circulating kidney injury molecule-1 as a prognostic biomarker for long-term renal outcomes in lupus nephritis: a retrospective cohort study.

Circulating kidney injury molecule-1 as a prognostic biomarker for long-term renal outcomes in lupus nephritis: a retrospective cohort study.

Journal: Lupus science & medicine

Published: March 24, 2026

Iatrogenic immunodeficiency-associated polymorphic lymphoproliferative disorder resulting in complete remission after tacrolimus withdrawal in systemic lupus erythematosus: a case report.

Iatrogenic immunodeficiency-associated polymorphic lymphoproliferative disorder resulting in complete remission after tacrolimus withdrawal in systemic lupus erythematosus: a case report.

Journal: Modern rheumatology case reports

Published: January 21, 2026

Interstitial palladin expression is associated with increased risk of end-stage kidney disease and death in patients with biopsy-proven diabetic kidney disease.

Interstitial palladin expression is associated with increased risk of end-stage kidney disease and death in patients with biopsy-proven diabetic kidney disease.

Journal: Clinical and experimental nephrology

Published: December 30, 2025

The C-terminal region of KIF26B is indispensable for nephron progenitor condensation and kidney formation in mice.

The C-terminal region of KIF26B is indispensable for nephron progenitor condensation and kidney formation in mice.

Journal: FEBS open bio

Published: December 22, 2025

Efficacy and safety of canakinumab in patients with adult-onset Still's disease: Results from an open-label phase III study in Japan.

Efficacy and safety of canakinumab in patients with adult-onset Still's disease: Results from an open-label phase III study in Japan.

Journal: Modern rheumatology

Published: November 27, 2025

d-Alanine Hydrochloride and d-Alanine Dipeptide Have Biological Activity and Promote Human Proximal Tubular Epithelial Cell Viability.

d-Alanine Hydrochloride and d-Alanine Dipeptide Have Biological Activity and Promote Human Proximal Tubular Epithelial Cell Viability.

Journal: Chemistry & biodiversity

Published: September 27, 2025

Clinical Images: Progressive calcinosis cutis universalis involving the intrapelvic muscles in systemic lupus erythematosus.

Clinical Images: Progressive calcinosis cutis universalis involving the intrapelvic muscles in systemic lupus erythematosus.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: July 25, 2025

Anti-MDA5 antibody-positive interstitial lung disease without prominent skin or muscle manifestations: A high-risk and potentially overlooked subgroup.

Anti-MDA5 antibody-positive interstitial lung disease without prominent skin or muscle manifestations: A high-risk and potentially overlooked subgroup.

Journal: Respiratory medicine

Published: July 23, 2025

Showing 1-12 of 136

Last Updated: 09/26/2026